The Future of U.S. Science Policy

The Future of U.S. Science Policy Illustrations by Jordan Domont With an administration change at hand, research could come out of the shadows and into the political light. By Bob Grant Article Extras Ken Thorpe Egils Milbergs John Porter Lana Skirboll 2008 Election Coverage Vote for the next president Which biologist would you elect president? Science and Politics Careers: The Scientist as Politician In late 2001, the George W. Bush

Written byRobert E. Pacifici and David P. Rankin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

By Bob Grant

Ken Thorpe

Egils Milbergs

John Porter

Lana Skirboll

2008 Election Coverage

Vote for the next president

Which biologist would you elect president?

Science and Politics

Careers: The Scientist as Politician

In late 2001, the George W. Bush Administration stripped the Office of Science and Technology Policy director John Marburger of his official title - "assistant to the president" - and moved the office from its longtime home in the Old Executive Building in the White House complex to a site blocks removed from the Oval Office. It was a short distance, but symbolic, say critics of how the administration has handled science.

On top of frequent news articles quoting accusations of government meddling in science over the past few years, scientists have lamented the plateauing of the National Institutes of Health budget, and the woeful rate of acceptance for NIH grant applications (in 2005, only about 9% ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform